Valproate overdose leading to hyperammonaemic encephalopathy
- PMID: 37423637
- PMCID: PMC10335463
- DOI: 10.1136/bcr-2023-255319
Valproate overdose leading to hyperammonaemic encephalopathy
Abstract
Sodium valproate is a commonly prescribed anticonvulsant medication; however, it can cause uncommon side effects such as hyperammonaemia and encephalopathy. We present the case of a male in his early 50s brought to the emergency department after being found collapsed by his wife, with an empty bottle of sodium valproate tablets. The patient developed hyperammonaemic encephalopathy due to sodium valproate overdose and was treated with supportive care and renal replacement therapy. This case highlights the importance of recognising the potential complications of sodium valproate and its prompt treatment.
Keywords: adult intensive care; drugs: cns (not psychiatric); neurology (drugs and medicines); toxicology.
© BMJ Publishing Group Limited 2023. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
References
-
- NICE . BNF is only available in the UK. NICE, Available: https://bnf.nice.org.uk/drugs/sodium-valproate/#side-effects [Accessed 29 Dec 2022].
-
- Dinçer M, Akgün A, Bodur Ş, et al. Hyperammonemic encephalopathy without hepatic dysfunction due to treatment with valproate: four cases and a mini review. Psychiatry and Clinical Psychopharmacology 2018;28:448–60. 10.1080/24750573.2018.1448133 - DOI
-
- Isidahome E, San Gabriel M. Valproic acid-induced Hyperammonemic encephalopathy (VIHE) in a patient with bipolar disorder: A case report and literature review. Eur Psychiatr 2022;65:S346. 10.1192/j.eurpsy.2022.880 - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical